191 related articles for article (PubMed ID: 11231354)
1. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.
Hou FF; Miyata T; Boyce J; Yuan Q; Chertow GM; Kay J; Schmidt AM; Owen WF
Kidney Int; 2001 Mar; 59(3):990-1002. PubMed ID: 11231354
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
[TBL] [Abstract][Full Text] [Related]
3. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
5. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of beta(2)-microglobulin amyloidosis: role of monocytes/macrophages.
Hou FF; Reddan DN; Seng WK; Owen WF
Semin Dial; 2001; 14(2):135-9. PubMed ID: 11264784
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional characteristics of macrophage-like cells differentiated in pro-inflammatory cytokine-containing cultures.
Hou FF; Boyce J; Zhang Y; Owen WF
Immunol Cell Biol; 2000 Jun; 78(3):205-13. PubMed ID: 10849108
[TBL] [Abstract][Full Text] [Related]
8. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures.
Becker S; Warren MK; Haskill S
J Immunol; 1987 Dec; 139(11):3703-9. PubMed ID: 2824612
[TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
[TBL] [Abstract][Full Text] [Related]
11. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
12. Effect of a novel adsorbent on cytokine responsiveness to uremic plasma.
Morena MD; Guo D; Balakrishnan VS; Brady JA; Winchester JF; Jaber BL
Kidney Int; 2003 Mar; 63(3):1150-4. PubMed ID: 12631100
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
Iwashima Y; Eto M; Hata A; Kaku K; Horiuchi S; Ushikubi F; Sano H
Biochem Biophys Res Commun; 2000 Oct; 277(2):368-80. PubMed ID: 11032732
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.
Boyle JJ; Weissberg PL; Bennett MR
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1553-8. PubMed ID: 12869351
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.
Figarola JL; Shanmugam N; Natarajan R; Rahbar S
Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432
[TBL] [Abstract][Full Text] [Related]
16. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells.
Rashid G; Benchetrit S; Fishman D; Bernheim J
Kidney Int; 2004 Sep; 66(3):1099-106. PubMed ID: 15327404
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis.
Hou FF; Jiang JP; Guo JQ; Wang GB; Zhang X; Stern DM; Schmidt AM; Owen WF
J Am Soc Nephrol; 2002 May; 13(5):1296-1306. PubMed ID: 11961018
[TBL] [Abstract][Full Text] [Related]
18. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
Kirstein M; Aston C; Hintz R; Vlassara H
J Clin Invest; 1992 Aug; 90(2):439-46. PubMed ID: 1322940
[TBL] [Abstract][Full Text] [Related]
19. Beta-microglobulin modified with advanced glycation end-products induces monocyte chemotaxis in vivo.
Cai Z; Miyata T; Horie K; Iida Y; Maeda K
Nephrol Dial Transplant; 1996 Jun; 11(6):1189-91. PubMed ID: 8671999
[No Abstract] [Full Text] [Related]
20. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
